Hologic Inc at Goldman Sachs Global Healthcare Conference Transcript
We can look to get started. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Steve MacMillan from Hologic, CEO, with us. There's 35-minute sessions, certainly open to questions. If you have any, just feel free to raise your hand. We'll try to look through the lights here.
But Steve, I think you wanted to just open with a few comments, then we can dive into Q&A.
Sure, Patrick. First off, thanks for having us. Great to see you.
I think at the highest level, as you look at the company today, what we feel really good about is -- and I'd say it's kind of for the first time certainly in my tenure in 5.5 years, whatever, where we have our largest businesses going in a great trajectory as well as both U.S. and internationally. So said simply, we've got our Breast Health business doing well in the U.S. and internationally. We have our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |